Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 868  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  » Next article
  » Previous article 
  » Table of Contents
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (125 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 »  Materials and Me...
 »  Results
 »  Discussion
 »  Acknowledgments
 »  References
 »  Article Tables

 Article Access Statistics
    Viewed11807    
    Printed215    
    Emailed10    
    PDF Downloaded507    
    Comments [Add]    
    Cited by others 39    

Recommend this journal

 


 
ORIGINAL ARTICLE
Year : 2005  |  Volume : 53  |  Issue : 2  |  Page : 191-196

Prognostic clinical variables in childhood tuberculous meningitis: An experience from Mumbai, India


1 Departments of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India
2 Departments of Radiology, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai, India

Date of Acceptance06-Mar-2005

Correspondence Address:
Sunil Karande
Flat 24, Joothica, 5th Floor, 22A, Naushir Bharucha Road, Mumbai – 400 007
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.16407

Rights and Permissions

 » Abstract 

Background: In India, tuberculous meningitis (TBM) is still a major cause of neurological disabilities and death. Aim: To identify the clinical variables which predict the outcome in childhood TBM. Setting: Tertiary teaching hospital. Design: Prospective observational study. Materials and Methods: Thirty-six clinical variables were analyzed in 123 consecutive children with TBM admitted between May 2000 and August 2003. The outcome was assessed in terms of survival or death. Survival meant that the patient was discharged from hospital having made a complete recovery, or with disability. Results: Twenty-five (20%) children recovered completely, 70 (57%) survived with disability, and 28 (23%) died. Employing univariate analysis nine variables correlated with survival with disability outcome: presence of tonic motor posturing, cranial nerve palsy, focal neurological deficit, hypertonia, moderate to severe hydrocephalus, cerebral infarction on cranial CT, and requiring shunt surgery, and absence of extracranial tuberculosis and no antituberculous-related hepatotoxicity; two variables correlated with fatal outcome: presence of deep coma (Glasgow coma scale score < 6), and absence of extrapyramidal movements. When logistic regression was applied only the presence of hypertonia ( P = 0.012, d.f. = 1, OR 0.12, 95% CI 0.02-0.62) correlated with survival with disability outcome, and presence of deep coma (P = 0.030, d.f. = 1, OR 0.35, 95% CI 0.14-0.90) with fatal outcome. Conclusion: In children with TBM, the presence of hypertonia at admission is an independent predictor of neurological sequelae in survivors, and deep coma is an independent predictor of mortality.


Keywords: Hydrocephalus, meningeal tuberculosis, multivariate analysis, prognosis, computed tomography


How to cite this article:
Karande S, Gupta V, Kulkarni M, Joshi A. Prognostic clinical variables in childhood tuberculous meningitis: An experience from Mumbai, India. Neurol India 2005;53:191-6

How to cite this URL:
Karande S, Gupta V, Kulkarni M, Joshi A. Prognostic clinical variables in childhood tuberculous meningitis: An experience from Mumbai, India. Neurol India [serial online] 2005 [cited 2021 May 7];53:191-6. Available from: https://www.neurologyindia.com/text.asp?2005/53/2/191/16407


The incidence of tuberculosis (TB) is on the increase worldwide.[1] Between 1 and 2% of children with untreated extracranial TB develop tuberculous meningitis (TBM).[2] Several retrospective[3],[4],[5],[6] and prospective[7],[8],[9] studies have been conducted to predict the outcome of TBM in childhood. However, most of the data were in the pre computed tomography (CT) scan era,[3],[4] and also the treatment protocols were not uniform or were inadequate as per current recommendations.[3],[4],[5] These studies by univariate analysis identified 14 clinical variables significantly associated with a poor outcome: (i) young age,[3],[4],[8],[9] (ii) male sex,[9] (iii) prolonged duration of symptoms,[3] (iv) seizures,[5] (v) advanced stage of the disease,[3],[4],[6],[7],[8],[9] (vi) coma,[9] (vii) tonic motor posturing,[9] (viii) papilloedema,[9] (ix) cranial nerve palsy,[9] (x) focal neurological deficit,[9] (xi) hydrocephalus,[7] (xii) associated miliary TB,[3] (xiii) absence of extra-cranial TB,[5] and (xiv) requiring shunt surgery.[5] Only three studies in childhood TBM[4],[5],[9] have employed multivariate analysis to identify significant prognostic variables, and only one [9] was conducted prospectively. Multivariate analysis has identified seven ' independent clinical variables ' which adversely affect the outcome, viz. (i) young age,[4],[9] (ii) seizures,[5] (iii) advanced stage of disease,[4],[9] (iv) tonic motor posturing,[9] (v) papilloedema,[9] (vi) focal neurological deficit,[9] and (vii) absence of extracranial TB.[5]

The aim of the present study was to identify the clinical variables, which predict the outcome of TBM in children.


 » Materials and Methods Top


Patient enrolment

Children with TBM, aged between 1 month and 12 years admitted to our hospital were enrolled prospectively. The study was conducted over a period of 40 months, from May 2000 to August 2003. The patient sample was by necessity a convenience sample, and all patients who met the study criteria were included in the study. All patients had an informed consent form signed by their parents.

The diagnosis of TBM was based on the clinical case definition [Table - 1] devised by Doerr et al .[10] All children had comprehensive physical and neurologic examination at the time of admission. Cerebrospinal fluid (CSF) examination and cranial CT scan were done soon after admission in every child. A standardized data entry form was used to document demographic data, clinical symptoms and signs, laboratory findings, Mantoux test result, chest radiograph and ultrasound of the abdomen findings, CSF, and cranial CT scan findings of each patient at presentation. Each patient was screened for human immunodeficiency virus (HIV) infection using the enzyme-linked immunosorbent assay (ELISA) test. Pre and post-test counseling for HIV infection was offered to the parents. The ELISA kits met the minimum standards (sensitivity > 99%, specificity > 95%) as recommended by the World Health Organization (WHO).[11] The diagnosis of HIV infection was confirmed as per the WHO strategy II: when two ELISA tests based on different antigen preparations and/or different principles were positive.[12] Family members were screened for tuberculous infection.

Nutritional status of the child was assessed by the Wellcome classification.[13] The severity of the disease at admission was classified as per the Medical Research Council (MRC) guidelines:[14] Stage I (early) = conscious, nonspecific symptoms, and no neurological signs; Stage II (intermediate) = signs of meningeal irritation with slight or no clouding of sensorium, with or without minor neurological deficit (cranial nerve palsy or limb paresis); Stage III (advanced) = severe clouding of sensorium, convulsions, focal neurological deficit, and/or involuntary movements. The child's level of consciousness was assessed by Glasgow coma scale (GCS).[15] The degree and significance of hydrocephalus on the cranial CT scan was calculated by ventricular size index (VSI), a ratio of bifrontal diameter over the frontal horn diameter.[16] A VSI of 30-38% indicates mild hydrocephalus, 39-45% moderate hydrocephalus, and >45% severe hydrocephalus.[16]

Management of cases

All children received standard antituberculous therapy (ATT) as recommended by the Indian Academy of Pediatrics:[17] isoniazid (5 mg/kg/day), rifampicin (10 mg/kg/day), pyrazinamide (25 mg/kg/day), and ethambutol (20 mg/kg/day); other supportive measures (steroids, anticonvulsants, and mannitol) within 24-48 h of admission. Pyrazinamide and ethambutol were discontinued after 2 months, and isoniazid and rifampicin continued for another 4 months. Corticosteroids were administered during the first month, intravenous dexamethasone (0.6-1.2 mg/kg/day in three divided doses) for the first 7 days, followed by oral prednisolone (2 mg/kg/day in three divided doses) and then gradually tapered over a week. Children with mild to moderate hydrocephalus received acetazolamide (20 mg/kg/day orally in three divided doses).

All the children who had neurological deterioration during the course of the hospital stay had repeated cranial CT. Children with moderate to severe hydrocephalus and neurologic deterioration received ventriculoperitoneal (VP) shunt.[18] When the CSF protein was more than 1 g/l, the child received initial external ventricular drainage using a chamber and later it was converted to VP shunt with the decrease in CSF protein. Liver function tests were done initially at a weekly interval to monitor ATT-related hepatotoxicity.

Outcome assessment

Survival
or death was the outcome measure. Survival was further categorized into: (i) discharge with ' complete recovery ' (no neurologic deficit), (ii) discharge with 'disability' (neurologic deficit).

Data analysis

The data were analyzed using the Statistical Package for Social Sciences, Version 11 for Windows (SPSS, Chicago, IL, USA). A univariate analysis was initially performed by the chi-square test to assess the relationship between the 36 variables and the three outcomes, viz. complete recovery, survival with disability, and death. Applying logistic regression to significant variables obtained in the univariate analysis, multivariate analysis was performed. Wherever appropriate the odds ratio (OR) was calculated and 95% confidence intervals (CI) were estimated around the OR. Statistical significance was considered as P value < 0.05. The power of analysis for the present study was 80%.


 » Results Top


One hundred and twenty-three children were studied [Table - 2]. The mean age was 3.1 years (range 3 months-12 years; ±SD 2.7 years). Almost one-third of the children were malnourished: 34 had marasmus, 3 had kwashiorkor, and 1 had marasmic-kwashiorkor. Three-fourth of the children had extracranial TB: with pulmonary involvement in 87 (71%), lymphadenopathy in 35 (28%), and abdominal involvement in 34 (28%). Forty-one (33%) children had cranial nerve palsy: 34 had facial palsy, 20 had abducens palsy, and four had oculomotor palsy. At admission, 5 (4%) children had Stage I disease, 12 (10%) had Stage II disease, and 106 (86%) had Stage III disease.

Cerebrospinal fluid examination was abnormal in all the children. Cellular response was lymphocytic predominance in 98 (80%) children. The means (range) of CSF cell count, protein, and glucose were 254 (8-8200) cells/mm3, 1.6 (0.2-8.4) g/l, and 0.43 (0.1-1.5) g/l, respectively. Admission cranial CT scan was abnormal in 121 (98%) children and the hydrocephalus was the common abnormal finding in 103 (84%) children, mild in 46 (37%), moderate in 45 (37%), and severe in 12 (10%). Sixty-nine (56%) children required shunt surgery. In three (2%) children, ATT-induced hepatitis necessitated modified drug regimens.

Of the 123 children studied, 25 (20%) made complete recovery (2 with Stage I disease, 4 with Stage II disease, and 19 with Stage III disease), 70 (57%) survived with disability (3 with Stage I, 5 with Stage II, and 62 with Stage III), and 28 (23%) died (none with Stage I, 3 in Stage II, and 25 with Stage III). The mean length of stay for children who survived to discharge was 19.8 (5-90, ±11.7) days; for those who died was 20.8 (3-45, ±17.6) days.

On univariate analysis, nine variables were found to be the predictors of good outcome, 'complete recovery:' the presence of extracranial TB ( P = 0.010, d.f. = 1) and ATT-induced hepatotoxicity ( P = 0.043, d.f. = 1); the absence of tonic posturing ( P = 0.004, d.f. = 1), cranial nerve palsy ( P = 0.039, d.f. = 1), focal neurological deficit ( P < 0.001, d.f. = 1), hypertonia ( P = 0.006, d.f. = 1), moderate-severe hydrocephalus ( P = 0.004, d.f. = 2), cerebral infarction ( P = 0.002, d.f. = 1), and shunt surgery being required ( P = 0.023, d.f. = 1). Nine variables were found to be associated with 'survival with disability' outcome [Table - 2]: the presence of tonic posturing ( P = 0.004, d.f. = 1), cranial nerve palsy ( P = 0.016, d.f. = 1), focal neurological deficit ( P < 0.001, d.f. = 1), hypertonia ( P = 0.003, d.f. = 1), moderate-severe hydrocephalus ( P = 0.005, d.f. = 2), cerebral infarction ( P = 0.001, d.f. = 1), and shunt surgery being required ( P = 0.014, d.f. = 1); absence of extracranial TB ( P = 0.020, d.f. = 1) and ATT-induced hepatotoxicity ( P = 0.017, d.f. = 1). Of the 19 (15%) children without extracranial TB who survived, 18 survived with disability and only one patient made a complete recovery. Of the 93 (76%) who survived without developing ATT-induced hepatotoxicity, 70 survived with disability and only 23 made a complete recovery [Table - 2]. When multivariate analysis was done using logistic regression analysis [Table - 3], no variable proved to be independently associated with good outcome 'complete recovery' and only the presence of hypertonia at presentation ( P = 0.012, d.f. = 1, OR 0.12, 95% CI 0.02-0.62) was found to be independently associated with the outcome, 'survival with disability.'

Univariate analysis identified two variables to be associated with a fatal outcome: presence of deep coma ( P = 0.018, d.f. = 1), and absence of extrapyramidal movements ( P = 0.031, d.f. = 1) at presentation. Of the 109 (89%) children who did not have extrapyramidal movements at presentation, 28 died and 81 survived, of which, 23 made a complete recovery and 58 survived with disability [Table - 2]. On multivariate analysis [Table - 3], only the presence of deep coma ( P = 0.030, d.f. = 1, OR 0.35, 95% CI 0.14-0.90) proved to be independently associated with fatal outcome.


 » Discussion Top


Ours is probably the first study where clinical variables that predict complete recovery, survival with disability, and fatal outcome have been identified separately. In other studies[3],[4],[5],[6],[7],[8],[9] both death and survival with moderate to severe disability were included in the poor outcome group. In the present study, 57% of the children survived with neurologic sequelae and 23% died. The reported incidence of neurologic disability in other studies[3],[4],[5],[6],[7],[8],[9] varied between 32 and 56%. The reported mortality ranged from 7 to 38%. When compared to the other prospective study of TBM in childhood,[9] our study had a higher number of patients (123 vs 50) and we analyzed more variables (36 vs 24).

Some of the variables found to be associated with 'survival with disability' on univariate analysis in our study, like hypertonia at the time of presentation, presence of cerebral infarction on CT, and no ATT-induced hepatotoxicity, have not been reported in the earlier studies on childhood TBM,[3],[4],[5],[6],[7],[8],[9] Cerebral infarction occurs in 14-38% of children with TBM, most commonly from the involvement of medial striate and thalamoperforating arteries.[19],[20] This probably explains the associated disability seen in survivors. We have no proper explanation for why the absence of ATT-induced hepatotoxicity was associated with an outcome, 'survival with disability' and also absence of extrapyramidal movement disorders was associated with a fatal outcome. These aspects need detailed studies.

The results of univariate analysis do not adjust for the effect of covariates and therefore have obvious limitations. In the present study, multivariate analysis demonstrated that hypertonia at admission was the only independent predictor of the outcome 'survival with disability' and deep coma with a fatal outcome. When the power of the study was rechecked for these two significant variables, it was 76.4% for hypertonia as a predictor of the outcome 'survival with disability' and 86.9% for deep coma as predictor of fatal outcome. These precise findings have not been reported in earlier studies.[4],[5],[9]

The strengths of the present study are that: (i) it was a prospective study including 123 children, (ii) patient population received uniform treatment protocols, and (iii) a large number of variables were analyzed for significance. However, the present study has its limitations. First, the diagnosis of TBM was based on clinical criteria and not on microbiological confirmation. Although definitive diagnosis of TBM depends on the detection of the tubercle bacilli in the CSF, either by smear examination or by bacterial culture; smears are usually positive in fewer than 10% of cases of TBM, while culture for Mycobacterium tuberculosis takes up to 8 weeks and also often negative.[18],[21] Most studies on outcome in childhood TBM have similarly diagnosed patients predominantly on clinical criteria.[3],[4],[5],[6],[7],[9] Second, the neurological outcome in children who survived was assessed purely on clinical examination at the time of discharge. We did not perform formal intelligence quotient or audiological evaluations. Third, since follow up after discharge from hospital is generally poor in our setting, we could not document the outcome after completion of ATT.

In conclusion, the present study documents that TBM continues to be a serious childhood illness with a high neurologic morbidity and mortality. We report that in children with TBM on admission to hospital the presence of hypertonia is an independent predictor of neurological sequelae in survivors, and the presence of deep coma is an independent predictor of mortality. Additional prospective studies employing multivariate analysis are required to determine the generalization of our findings.


 » Acknowledgments Top


We thank our Dean, Dr. M. E. Yeolekar, for granting us permission to publish the hospital data; our Biostatistician, Mr. Kailas Gandewar, and Dr. D.P. Singh, Reader, Department of Research Methodology, Tata Institute of Social Sciences, Deonar, Mumbai for their help in the statistical analysis of the data.



 
 » References Top

1.Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Starke JR. Tuberculosis of the central nervous system in children. Semin Pediatr Neurol 1999;6:318-31.  Back to cited text no. 2  [PUBMED]  
3.Delage G, Dusseault M. Tuberculous meningitis in children: a retrospective study of 79 patients, with an analysis of prognostic factors. Can Med Assoc J 1979;120:305-9.  Back to cited text no. 3  [PUBMED]  
4.Humphries MJ, Teoh R, Lau J, Gabriel M. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle 1990;71:161-8.  Back to cited text no. 4  [PUBMED]  
5.Paganini H, Gonzalez F, Santander C, Casimir L, Berberian G, Rosanova MT. Tuberculous meningitis in children: clinical features and outcome in 40 cases. Scand J Infect Dis 2000;32:41-5.  Back to cited text no. 5  [PUBMED]  
6.Lee LV. Neurotuberculosis among Filipino children: an 11 years experience at the Philippine Children's Medical Center. Brain Dev 2000;22:469-74.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]
7.Altunbasak S, Alhan E, Baytok V, Aksaray N, Yuksel B, Onenli N. Tuberculous meningitis in children. Acta Paediatr Jpn 1994;36:480-4.  Back to cited text no. 7  [PUBMED]  
8.Thilothammal N, Krishnamurthy PV, Banu K, Ratnam SR. Tuberculous meningitis in children-clinical profile, mortality and morbidity of bacteriologically confirmed cases. Indian Pediatr 1995;32:641-7.  Back to cited text no. 8  [PUBMED]  
9.Mahadevan B, Mahadevan S, Serane VT. Prognostic factors in childhood tuberculous meningitis. J Trop Pediatr 2002;48:362-5.  Back to cited text no. 9  [PUBMED]  [FULLTEXT]
10.Doerr CA, Starke JR, Ong LT. Clinical and public health aspects of tuberculous meningitis in children. J Pediatr 1995;127:27-33.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]
11.Joint United Nations Programme on HIV/AIDS (UNAIDS) - World Health Organization. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997;72:81-8.  Back to cited text no. 11    
12.Dodd CL, Greenspan D, Katz MH, Westenhouse JL, Feigal DW, Greenspan JS. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression to AIDS. AIDS 1991;5:1339-43.   Back to cited text no. 12  [PUBMED]  
13.Wellcome Trust Working Party. Classification of infantile malnutrition. Lancet 1970;ii:302-3.  Back to cited text no. 13    
14.Medical Research Council. Streptomycin in Tuberculosis Trials Committee. Streptomycin treatment of tuberculous meningitis. Lancet 1948;i:582-96.   Back to cited text no. 14    
15.Teasdale GM, Jennett B. Assessment and prognosis of coma after head injury. Acta Neurochir (Wien) 1976;34:45-55.   Back to cited text no. 15    
16.TerBrugge KG, Rao KC, Lee SH. Hydrocephalus and atrophy. In : Lee SH, Rao KC, editors. Cranial Computed Tomography and MRI. 2nd ed. New York: McGraw Hill; 1987. pp231-62.  Back to cited text no. 16    
17.Indian Academy of Pediatrics. Treatment of childhood tuberculosis: Consensus Statement of IAP Working Group. Indian Pediatr 1997;34:1093-6.  Back to cited text no. 17  [PUBMED]  
18.Newton RW. Tuberculous meningitis. Arch Dis Child 1994;70:364-6.   Back to cited text no. 18  [PUBMED]  
19.Ozates M, Kemaloglu S, Gurkan F, Ozkan U, Hosoglu S, Simsek MM. CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol 2000;41:13-7.  Back to cited text no. 19  [PUBMED]  [FULLTEXT]
20.Hsieh FY, Chia LG, Shen WC. Locations of cerebral infarctions in tuberculous meningitis. Neuroradiology 1992;34:197-9.  Back to cited text no. 20  [PUBMED]  
21.Kumar R, Singh SN, Kohli N. A diagnostic rule for tuberculous meningitis. Arch Dis Child 1999;81:221-4.  Back to cited text no. 21  [PUBMED]  [FULLTEXT]


Tables

[Table - 1], [Table - 2], [Table - 3]

This article has been cited by
1 A predictive score followed by nucleic acid amplification for adult tuberculous meningitis diagnosis in Southern Brazil
Lívia Maria Pala Anselmo,Cinara Feliciano,Fernando Mauad,Margarida Passeri do Nascimento,Renata Candido Pocente,Jorgete Maria Silva,Valdes Roberto Bollela
Journal of the Neurological Sciences. 2017; 379: 253
[Pubmed] | [DOI]
2 Tuberculosis in Children
Tania A. Thomas
Pediatric Clinics of North America. 2017; 64(4): 893
[Pubmed] | [DOI]
3 Six months therapy for tuberculous meningitis
Sophie Jullien,Hannah Ryan,Manish Modi,Rohit Bhatia
Cochrane Database of Systematic Reviews. 2016;
[Pubmed] | [DOI]
4 Clinical characteristics and neurodevelopmental outcomes of children with tuberculous meningitis and hydrocephalus
Ursula K Rohlwink,Kirsty Donald,Bronwyn Gavine,Llewellyn Padayachy,Jo M Wilmshurst,Graham A Fieggen,Anthony A Figaji
Developmental Medicine & Child Neurology. 2016; : n/a
[Pubmed] | [DOI]
5 Otomastoiditis crónica, el origen parameníngeo de una meningitis tuberculosa
José Luis Monsalve Londońo,Hernán Darío Aguirre Henao,Andrés Felipe Posada,Lorena Jiménez,Adriana Bryon
Neurología Argentina. 2016;
[Pubmed] | [DOI]
6 Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children
RM Savic,R Ruslami,JE Hibma,A Hesseling,G Ramachandran,AR Ganiem,S Swaminathan,H McIlleron,A Gupta,K Thakur,R van Crevel,R Aarnoutse,KE Dooley
Clinical Pharmacology & Therapeutics. 2015; 98(6): 622
[Pubmed] | [DOI]
7 Central Nervous System Tuberculosis: Clinical Characteristics and Outcome. A Saudi Tertiary Care Centre Experience
Mohammad Bo Saeed,Adel Alothman,Suleiman Kojan,Suliman Almahmoud,Ali Al Khathaami,Mohammed Al Ghobain
Advances in Infectious Diseases. 2015; 05(01): 63
[Pubmed] | [DOI]
8 Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis
Silvia S Chiang,Faiz Ahmad Khan,Meredith B Milstein,Arielle W Tolman,Andrea Benedetti,Jeffrey R Starke,Mercedes C Becerra
The Lancet Infectious Diseases. 2014;
[Pubmed] | [DOI]
9 Clinicodiagnostic features of tuberculous meningitis and the role of CSF PCR in early diagnosis: A study from North-west India
Panagariya, A. and Sureka, R.K. and Ralot, T. and Sharma, B. and Dubey, P.
Journal of the Indian Medical Association. 2013; 111(5): 309-314
[Pubmed]
10 Directly observed treatment, short course in tuberculous meningitis: Indian perspective
Sharma, S.R. and Lynrah, K.G. and Sharma, N. and Lyngdoh, M.
Annals of Indian Academy of Neurology. 2013; 16(1): 82-84
[Pubmed]
11 Causal Inference Regarding Infectious Aetiology of Chronic Conditions: A Systematic Review
Sofia Orrskog,Emma Medin,Svetla Tsolova,Jan C. Semenza,Michael Bouchard
PLoS ONE. 2013; 8(7): e68861
[Pubmed] | [DOI]
12 Diagnosis and therapy of tuberculous meningitis in children
Nicola Principi,Susanna Esposito
Tuberculosis. 2012; 92(5): 377
[Pubmed] | [DOI]
13 Prognostic Value of Computed Tomography-Evident Cerebral Infarcts in Adult Patients with Tuberculous Meningitis and Hydrocephalus Treated with an External Ventricular Drain
Tiago Clemente Morgado,Max Kinsky,Henri Carrara,Sally Rothemeyer,Patrick Semple
World Neurosurgery. 2012;
[Pubmed] | [DOI]
14 Clinical and radiological prognostic indicators in childhood tuberculous meningitis
Goyal, S. and Kohli, N. and Jain, A. and Dixit, P. and Chandrakanta and Kumar, R.
Journal of Pediatric Neurology. 2012; 10(3): 181-186
[Pubmed]
15 Diagnosis and therapy of tuberculous meningitis in children
Principi, N. and Esposito, S.
Tuberculosis. 2012; 92(5): 377-383
[Pubmed]
16 Neurotuberculosis: An overview
Rodrigues, M.G. and da Rocha, A.J. and Masruha, M.R. and Minett, T.S.C.
Central Nervous System Agents in Medicinal Chemistry. 2011; 11(4): 246-260
[Pubmed]
17 Role of ventriculoperitoneal shunt surgery in grade IV tubercular meningitis with hydrocephalus
Jing Peng, Xiaolu Deng, Fang He, Ahmed Omran, Ciliu Zhang, Fei Yin, Jingping Liu
Child s Nervous System. 2011;
[VIEW] | [DOI]
18 Incidence, predictors and prognostic value of cranial nerve involvement in patients with tuberculous meningitis: A retrospective evaluation
Pawan Sharma, Ravindra Kumar Garg, Rajesh Verma, Maneesh Kumar Singh, Rakesh Shukla
European Journal of Internal Medicine. 2011; 22(3): 289
[VIEW] | [DOI]
19 HIV-associated tuberculous meningitis – diagnostic and therapeutic challenges
Suzaan Marais,Dominique J. Pepper,Ben J. Marais,M. Estée Török
Tuberculosis. 2010; 90(6): 367
[Pubmed] | [DOI]
20 Tuberculous meningitis: a uniform case definition for use in clinical research
Suzaan Marais,Guy Thwaites,Johan F Schoeman,M Estée Török,Usha K Misra,Kameshwar Prasad,Peter R Donald,Robert J Wilkinson,Ben J Marais
The Lancet Infectious Diseases. 2010; 10(11): 803
[Pubmed] | [DOI]
21 Tuberculous meningitis
Garg, R.K.
Acta Neurologica Scandinavica. 2010; 122(2): 75-90
[Pubmed]
22 Tuberculous meningitis: a uniform case definition for use in clinical research
Marais, S., Thwaites, G., Schoeman, J.F., Török, M.E., Misra, U.K., Prasad, K., Donald, P.R., (...), Marais, B.J.
The Lancet Infectious Diseases. 2010; 10(11): 803-812
[Pubmed]
23 HIV-associated tuberculous meningitis - Diagnostic and therapeutic challenges
Marais, S., Pepper, D.J., Marais, B.J., Török, M.E.
Tuberculosis. 2010; 90(6): 367-374
[Pubmed]
24 Tuberculous meningitis: a uniform case definition for use in clinical research
Marais, S. and Thwaites, G. and Schoeman, J.F. and Török, M.E. and Misra, U.K. and Prasad, K. and Donald, P.R. and Wilkinson, R.J. and Marais, B.J.
The Lancet Infectious Diseases. 2010; 10(11): 803-812
[Pubmed]
25 Outcome of ventriculoperitoneal shunt placement in Grade IV tubercular meningitis with hydrocephalus: a retrospective analysis in 95 patients : Clinical article
Umesh Srikantha, Jagadeesh V. Morab, Savitr Sastry, Rojin Abraham, Anandh Balasubramaniam, Sampath Somanna, Indira Devi, Chandramouli A. Bangalore, Paritosh Pandey
Journal of Neurosurgery Pediatrics. 2009; 4(2): 176-183
[Pubmed] | [DOI]
26 Tuberculous meningitis
R. K. Garg
Acta Neurologica Scandinavica. 2009;
[VIEW] | [DOI]
27 Update on Tuberculosis of the Central Nervous System: Pathogenesis, Diagnosis, and Treatment
Thwaites, G.E., Schoeman, J.F.
Clinics in Chest Medicine. 2009; 30(4): 745-754
[Pubmed]
28 Update on Tuberculosis of the Central Nervous System: Pathogenesis, Diagnosis, and Treatment
Guy E. Thwaites,Johan F. Schoeman
Clinics in Chest Medicine. 2009; 30(4): 745
[Pubmed] | [DOI]
29 La tuberculose méningée en milieu pédiatrique sénégalais : ŕ propos de 14 cas
B. Camara,A. Ly/Ba,P.M. Faye,A. Ba,I. Ba,S. Dia/Ndour,M. Ba,H.D. Sow
Archives de Pédiatrie. 2008; 15(3): 322
[Pubmed] | [DOI]
30 Tuberculosis meningitis in a senegalese pediatric hospital: Report of 14 cases | [La tuberculose méningée en milieu pédiatrique sénégalais : ŕ propos de 14 cas]
Camara, B., Ly-Ba, A., Faye, P.M., Ba, A., Ba, I., Dia-Ndour, S., Ba, M., Sow, H.D.
Archives de Pediatrie. 2008; 15(3): 322-324
[Pubmed]
31 Multi drug resistant tuberculous meningitis in pediatric age group
Baveja, C.P., Gumma, V., Jaint, M., Chaudharyz, M., Talukdar, B., Sharma, V.K.
Iranian Journal of Pediatrics. 2008; 18(4): 309-314
[Pubmed]
32 Stroke in central nervous system infections
Carod-Artal, F.
Annals of Indian Academy of Neurology. 2008; 11(SUPPL.5): S64-S78
[Pubmed]
33 Clinical profile of TBM children presenting in tertiary pediatric neurology unit
Naz, F. and Malik, M.A. and Malik, N.
Pakistan Paediatric Journal. 2008; 32(2): 105-110
[Pubmed]
34 Tuberculosis meningitis in a senegalese pediatric hospital: Report of 14 cases [La tuberculose méningée en milieu pédiatrique sénégalais : à propos de 14 cas]
Camara, B. and Ly-Ba, A. and Faye, P.M. and Ba, A. and Ba, I. and Dia-Ndour, S. and Ba, M. and Sow, H.D.
Archives de Pediatrie. 2008; 15(3): 322-324
[Pubmed]
35 Clinical, laboratory and radiological indicators for the early diagnosis of tuberculous meningitis in children
Sultan, T. and Malik, M.A. and Khan, M.M.N. and Ahmed, T.M.
Pakistan Paediatric Journal. 2007; 31(3): 142-148
[Pubmed]
36 New tools for a better diagnosis of latent tuberculosis infection [Nuovi strumenti per una migliore diagnosi dellćinfezione tubercolare latente]
Ferrara, G. and Losi, M. and Roversi, P. and Fabbri, L.M. and Richeldi, L.
Recenti Progressi in Medicina. 2006; 97(3): 123-128
[Pubmed]
37 Emergency and intensive care management of a comatose patient with intracranial hypertension: Current concepts
Ranjit, S.
Indian Pediatrics. 2006; 43(5): 409-415
[Pubmed]
38 Clinical, laboratory and computed tomographic features of tuberculous meningitis in children
Aftab, R., Ahmed, A.
Medical Forum Monthly. 2005; 16(4): 7-11
[Pubmed]
39 Tuberculous meningitis [13]
Shubhakaran and Rekha, J.
Neurology India. 2005; 53(3): 375-376
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article
Online since 20th March '04
Published by Wolters Kluwer - Medknow